AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiup M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Sk Laboratories Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimiup M 2mg/500mg Tablet SR

Diabetic patients using the anti-diabetic medication, Glimiup M 2mg/500mg SR tablets, manage their type 2 diabetes mellitus through this dual-action formulation. Administered with meals, consistent daily dosing maximizes its blood sugar regulation effects. Dosage is individualized by your physician, subject to adjustment based on your blood glucose readings. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, integrating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with fast-acting glucose sources (e.g., sugary foods, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any pre-existing heart conditions before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood sugar monitoring, along with blood tests to assess blood cell counts and liver function, are essential.

Primary Ingredients of Glimiup M 2mg/500mg Tablet SR

No text provided to rephrase.

Uses of Glimiup M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimiup M 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimiup M 2mg/500mg Sustained-Release Tablets with a meal.

Common Side effects of Glimiup M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiup M 2mg/500mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimiup M 2mg/500mg Sustained-Release tablets with a meal.

How Glimiup M 2mg/500mg Tablet SR works:

Glimiup M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimiup M 2mg/500mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimiup M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards before prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimiup M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimiup M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Caution is advised when prescribing Glimiup M 2mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification of Glimiup M 2mg/500mg SR tablets may be necessary. Physician consultation is recommended. For patients experiencing mild to moderate liver disease, Glimiup M 2mg/500mg SR tablets are typically initiated at a reduced dosage; however, its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Glimiup M 2mg/500mg Tablet SR :

Should you forget to take a Glimiup M 2mg/500mg Tablet SR, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimiup M 2mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Glimiup M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimiup M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimiup M 2mg/500mg Tablet SR and seek immediate medical attention.
Glimiup M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimiup M 2mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimiup M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimiup M 2mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimiup M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimiup M 2mg/500mg Table...
30
MRP 35
14% off